Published on 22 Jan 2024 on GuruFocus.com via Yahoo Finance
Pliant Therapeutics Inc CFO Keith Cummings Sells 9,781 Shares
Keith Cummings, the CFO of Pliant Therapeutics Inc, sold 9,781 shares of the company on January 17, 2024, according to a recent SEC filing. The transaction was executed at an average price of $17.23 per share, resulting in a total value of $168,553.63.Pliant Therapeutics Inc is a biopharmaceutical company focused on discovering, developing, and commercializing treatments for fibrotic diseases. The company's research seeks to target the underlying biological mechanisms that lead to fibrosis, aiming to create therapies that can halt or reverse the fibrotic process.Keith Cummings has a history of selling shares in the company over the past year, with a total of 69,512 shares sold and no shares purchased.The insider transaction history for Pliant Therapeutics Inc shows a pattern of insider sales, with 24 insider sells and no insider buys over the past year.
On the valuation front, Pliant Therapeutics Inc's shares were trading at $17.23 on the day of the insider's recent sale, giving the stock a market cap of $1.000 billion.The stock's price-to-GF-Value ratio stands at 5.49, indicating that Pliant Therapeutics Inc is significantly overvalued based on its GF Value of $3.14.